Immunophenotypic signature of primary glioblastoma multiforme: A case of extended progression free survival.

Gandhi, Puneet; Khare, Richa; Garg, Nitin; Sorte, Sandeep

Gandhi, Puneet; Khare, Richa; Garg, Nitin; Sorte, Sandeep.

Afiliação

Gandhi P; Puneet Gandhi, Richa Khare, Department of Research, Bhopal Memorial Hospital and Research Centre, Bhopal 462038, India.
Khare R; Puneet Gandhi, Richa Khare, Department of Research, Bhopal Memorial Hospital and Research Centre, Bhopal 462038, India.
Garg N; Puneet Gandhi, Richa Khare, Department of Research, Bhopal Memorial Hospital and Research Centre, Bhopal 462038, India.
Sorte S; Puneet Gandhi, Richa Khare, Department of Research, Bhopal Memorial Hospital and Research Centre, Bhopal 462038, India.

World J Clin Cases ; 5(6): 247-253, 2017 Jun 16.

Article em En | MEDLINE | ID: mdl-28685138

Palavras-chave

Glioblastoma multiforme; High mobility group-A1; Human telomerase reverse transcriptase; Immunophenotypic signature; Interleukin-6; Molecular markers; Progression free survival; Tissue inhibitor of metalloproteinases-1; YKL-40

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article